151 related articles for article (PubMed ID: 20161858)
1. Mucocutaneous changes in tuberous sclerosis complex: a clinical profile of 27 Indian patients.
Ghosh SK; Bandyopadhyay D; Chatterjee G; Ghosh A; Sarkar S; Sarkar S
Indian J Dermatol; 2009 Jul; 54(3):255-7. PubMed ID: 20161858
[TBL] [Abstract][Full Text] [Related]
2. Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama.
Cascarino M; Leclerc-Mercier S
Dermatopathology (Basel); 2021 Jul; 8(3):236-252. PubMed ID: 34287284
[TBL] [Abstract][Full Text] [Related]
3. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance.
Jóźwiak S; Schwartz RA; Janniger CK; Michałowicz R; Chmielik J
Int J Dermatol; 1998 Dec; 37(12):911-7. PubMed ID: 9888331
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.
Bongiorno MA; Nathan N; Oyerinde O; Wang JA; Lee CR; Brown GT; Moss J; Darling TN
JAMA Dermatol; 2017 Jul; 153(7):660-665. PubMed ID: 28445558
[TBL] [Abstract][Full Text] [Related]
5. Clinical and radiological findings related to tuberous sclerosis complex: a case report.
Gupta S; Bhowate R; Degwekar SS
J Contemp Dent Pract; 2008 May; 9(4):85-91. PubMed ID: 18473031
[TBL] [Abstract][Full Text] [Related]
6. Fibrous cephalic plaques in tuberous sclerosis complex.
Oyerinde O; Buccine D; Treichel A; Hong C; Lee CR; Moss J; Darling TN
J Am Acad Dermatol; 2018 Apr; 78(4):717-724. PubMed ID: 29258863
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of tuberous sclerosis cases.
Söğüt A; Ozmen M; Sencer S; Calişkan M; Aydinli N; Ertuğrul T; Peksayar G
Turk J Pediatr; 2002; 44(2):98-101. PubMed ID: 12026215
[TBL] [Abstract][Full Text] [Related]
8. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
9. A different approach for identifying hypomelanotic macules in tuberous sclerosis complex.
Gualandri L; Boccardi D; Menni S
G Ital Dermatol Venereol; 2015 Oct; 150(5):501-3. PubMed ID: 26333551
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
Malissen N; Vergely L; Simon M; Roubertie A; Malinge MC; Bessis D
J Am Acad Dermatol; 2017 Sep; 77(3):464-472.e3. PubMed ID: 28502378
[TBL] [Abstract][Full Text] [Related]
11. Tuberous Sclerosis.
Amorim BDB; Azulay D; Ramos-E-Silva M
Skinmed; 2021; 19(3):179-185. PubMed ID: 34303387
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Para clinical Manifestations of Tuberous Sclerosis: A Cross Sectional Study on 81 Pediatric Patients.
Tonekaboni SH; Tonekaboni SH; Tousi P; Ebrahimi A; Ahmadabadi F; Keyhanidoust Z; Zamani G; Rezvani M; Amirsalari S; Tavassoli A; Rounagh A; Rezayi A
Iran J Child Neurol; 2012; 6(3):25-31. PubMed ID: 24665269
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
[TBL] [Abstract][Full Text] [Related]
14. Tuberous Sclerosis Complex: Clinical Spectrum and Epilepsy: A Retrospective Chart Review Study.
Almobarak S; Almuhaizea M; Abukhaled M; Alyamani S; Dabbagh O; Chedrawi A; Khan S; Aldhalaan H
Transl Neurosci; 2018; 9():154-160. PubMed ID: 30479846
[TBL] [Abstract][Full Text] [Related]
15. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
[TBL] [Abstract][Full Text] [Related]
16. Forehead plaque: a cutaneous marker of CNS involvement in tuberous sclerosis.
Rama Rao GR; Krishna Rao PV; Gopal KV; Kumar YH; Ramachandra BV
Indian J Dermatol Venereol Leprol; 2008; 74(1):28-31. PubMed ID: 18187819
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of epilepsy in tuberous sclerosis.
Anisya-Vasanth AV; Satishchandra P; Nagaraja D; Swamy HS; Jayakumar PN
Neurol India; 2004 Jun; 52(2):210-2. PubMed ID: 15269473
[TBL] [Abstract][Full Text] [Related]
18. Recognizing an index case of tuberous sclerosis.
Hurst JS; Wilcoski S
Am Fam Physician; 2000 Feb; 61(3):703-8, 710. PubMed ID: 10695583
[TBL] [Abstract][Full Text] [Related]
19. Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.
Ghosh SK; Bandyopadhyay D; Saha I; Barua JK
Indian J Dermatol; 2012 May; 57(3):201-5. PubMed ID: 22707772
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex.
Islam MP; Roach ES
Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
